Therapy Reduces Chances of Dialysis

(Economic Times) – A research led by scientists of the Monash University has for the first time shown the effectiveness of combining a stem cell-based therapy with an anti-scarring agent which would reverse scarring and markers of kidney injury, thereby reducing the need for dialysis or transplantation. The researchers discovered that adult stem cells when combined with a protein called serelaxin, could reverse scarring.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.